cgrp receptor ramp1 clr fusion protein antagonists the calcitonin gene related peptide gcrp

navigate by keyword : pdb4rwg cgrp calcitonin receptor like receptorlike clr activitymodifying generelated peptide calcrl migraine nerve pain structure protein amino acid molecule polypeptide polymer atoms science scientific disease health molecular model rendering illustration white background

CGRP receptor (RAMP1:CLR fusion protein). Antagonists of the calcitonin gene-related peptide receptor (GCRP receptor antagonists) Royalty Free Stock Photo
CGRP receptor (RAMP1:CLR fusion protein). Antagonists of the calcitonin gene-related peptide receptor (GCRP receptor antagonists) Royalty Free Stock Photo
CGRP receptor (RAMP1:CLR fusion protein). Antagonists of the calcitonin gene-related peptide receptor (GCRP receptor antagonists) Royalty Free Stock Photo
CGRP receptor (RAMP1:CLR fusion protein). Antagonists of the calcitonin gene-related peptide receptor (GCRP receptor antagonists) Royalty Free Stock Photo
CGRP receptor (RAMP1:CLR fusion protein). Antagonists of the calcitonin gene-related peptide receptor (GCRP receptor antagonists) Royalty Free Stock Photo
   
   
CGRP receptor (RAMP1:CLR fusion protein). Antagonists of the calcitonin gene-related peptide receptor (GCRP receptor antagonists)
CGRP receptor (RAMP1:CLR fusion protein). Antagonists of the calcitonin gene-related peptide receptor (GCRP receptor antagonists) Royalty Free Stock Photo
CGRP receptor (RAMP1:CLR fusion protein). Antagonists of the calcitonin gene-related peptide receptor (GCRP receptor antagonists) Royalty Free Stock Photo
   
   
   
   
   
CGRP receptor (RAMP1:CLR fusion protein). Antagonists of the calcitonin gene-related peptide receptor (GCRP receptor antagonists) are investated for the treatment of migraine. 3D rendering based on protein data bank entry 4rwg. Atoms shown as color-coded spheres. Protein and CGRP analog shown in different colors


Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners.